ACP American College of Physicians - Internal Medicine - Doctors for Adults

Clinical Information

• Guidelines
• Performance Measurement
• PIER - Decision Support
• Journals & Publications
• Mobile Resources
• Additional Resources
  • Adult Immunization
  • High Value Care
  • Bioterrorism
  • Lyme Disease Initiative
  • End of Life Care
  • Explaining Kidney Test Results

Quick Facts about Plague

• Plague is caused by Yersinia pestis, a gram-negative bacillus
• Plague is a zoonosis that affects primarily rodents
• • Endemic to Arizona, Colorado, New Mexico, and California
  • Humans are "accidental hosts"
• Transmission occurs in one of five ways
• • Bites of infected fleas
  • Human to human transmission of pneumonic plague by respiratory droplets
  • Handling of infected animal carcasses
  • Cat bites or scratches
  • Deliberate aerosolization of bacteria
• Three plague syndromes are recognized
• • Bubonic
  • • The most common naturally occurring form of the disease
    • 2 to 8 days following inoculation symptoms include the abrupt onset of fevers chills, headache, and weakness
    • Painful proximal lymphadenopathy develops, most commonly in the inguinal, axillary, or cervical areas. Lymph nodes become enlarged, matted, and associated with extensive, overlying edema (buboes)
    • Gastrointestinal symptoms such as nausea, vomiting, and abdominal pain may occur
    • Bacteremia may follow, resulting in sepsis and death
  • Pneumonic
  • • The most likely presentation of a bioterrorist attack
    • Infection results from deliberate aerosolization of bacteria or contact with respiratory droplets from an infected person
    • Symptoms develop 1 to 6 days following exposure
    • Rapidly developing bronchopneumonia characterized by fever, cough, dyspnea, and serosanguineous sputum
    • The time from respiratory exposure to death ranges from 2 to 6 days
    • Suspicion of a deliberate attack should be raised by the rapid progression of a lethal pneumonia in a group of previously healthy people
  • Septicemic
  • • May arise secondary to bubonic plague or following a fleabite without the development of buboes
    • Septicemia is associated with disseminated intravascular coagulation, necrosis of small blood vessels, purpuric skin lesions, and acral gangrene
    • Death is the result of shock and multiple organ failure
• Diagnosis
• • Gram stain of the sputum or blood may reveal gram-negative bacilli or coccobacilli
  • Under the best of circumstances, cultures of sputum or blood are positive in 24to 48 hours. Depending on method used, results typically may take from 72 hours to 6 days
  • Rapid diagnostic tests, such as antigen detection, IgM enzyme immunoassay, immunostaining, and polymerase chain reaction are available only at selected state health departments, the CDC, and the military
  • Survival depends upon presumptive treatment prior to microbiological confirmation of the diagnosis
• Treatment (based upon the interim recommendations of the Working Group on Civilian Biodefense, Johns Hopkins University Schools of Medicine)
• • Adults: Preferred choices
  • • Streptomycin, 1 g IM BID
    • Gentamicin, 5 mg/kg IM or IV once daily or 2 mg/kg loading dose followed by 1.7 mg/kg IM or IV TID
  • Adults: Alternative choices
  • • Doxycycline, 100 mg IV BID or 200 mg IV once daily
    • Ciprofloxacin, 400 mg IV BID
    • Chloramphenicol, 25 mg/kg IV QID
  • Children: Preferred choices
  • • Streptomycin, 15 mg/kg IM BID, maximum dose 2 g
    • Gentamicin, 2.5 mg/kg IM or IV TID
  • Children: Alternative choices
  • • Doxycycline: If > 45 kg, give adult dose. If < 45 kg, give 2.2 mg/kg IV BID (maximum dose 200 mg/day)
    • Ciprofloxacin, 15 mg/kg IV BID
    • Chloramphenicol, 25 mg/kg IV QID
  • Pregnant women: Preferred choice
  • • Gentamicin, 5 mg/kg IM or IV once daily or 2 mg/kg loading dose followed by 1.7 mg/kg IM or IV TID
  • Pregnant women: Alternative choice
  • • Doxycycline, 100 mg IV BID or 200 mg IV once daily
    • Ciprofloxacin, 400 mg IV BID
  • Therapy should be continued for 10 days. Oral therapy should be substituted when patient's condition improves
• Post-exposure prophylaxis
• • Asymptomatic persons with household, hospital or other close contact (within 2 meters) with persons with untreated pneumonic plague
  • • Adults: oral doxycycline, 100 mg BID x 7 days
    • Children: if > 45 kg give adult oral doxycycline dosage. If < 45 kg, give oral doxycycline, 2.2 mg/kg BID x 7 days
    • Pregnant women: oral doxycycline, 100 mg BID x 7 days
  • Persons receiving post-exposure prophylaxis who develop fever or cough
  • • Antibiotic treatment as described above for pneumonic plague
  • Persons in a community experiencing a pneumonic plague outbreak who develop a fever > 38.5° C, or new cough, or infants with tachypnea
  • • Antibiotic treatment as described above for pneumonic plague
• Infection Control
• • Isolate patients for the first 48 hours of antibiotic therapy and until clinical improvement occurs
  • Transported patients should wear surgical masks
  • Observe standard respiratory droplet precautions including gowns, gloves, and eye protection for close contacts
  • Disinfect contaminated clothing and linens according to hospital protocol

• Jobs at ACP
• Contact Us
• Privacy
• Site Map
• For Advertisers
• For Media
• For Governors
• For Regents